|
US2802005A
(en)
|
|
1957-08-06 |
|
S-eluorourace |
|
US2331725A
(en)
|
1941-01-31 |
1943-10-12 |
Lederle Lab Inc |
Preparation of 2-methyl-1,4-naphthoquinone
|
|
US3205220A
(en)
|
1961-10-26 |
1965-09-07 |
Lilly Co Eli |
Leurosidine and leurocristine and their production
|
|
CH514578A
(de)
|
1968-02-27 |
1971-10-31 |
Sandoz Ag |
Verfahren zur Herstellung von Glucosiden
|
|
GB1457632A
(en)
|
1974-03-22 |
1976-12-08 |
Farmaceutici Italia |
Adriamycins
|
|
DD159877A1
(de)
|
1981-06-12 |
1983-04-13 |
Wolfgang Krueger |
Verfahren zur herstellung von 4-[1-methyl-5-bis(2-chloraethyl)amino-benzimidazolyl-2]-buttersaeure
|
|
OA07174A
(fr)
|
1981-08-24 |
1984-04-30 |
May & Baker Ltd |
Nouvelles imidazotétrazionones, leur préparation et les médicaments qui les contiennent.
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
ES8604088A1
(es)
|
1985-06-14 |
1986-01-16 |
Espanola Farma Therapeut |
Procedimiento para la obtencion de un compuesto derivado de un acido dicarboxilico
|
|
FR2601676B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Procede de preparation du taxol et du desacetyl-10 taxol
|
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5004758A
(en)
|
1987-12-01 |
1991-04-02 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
|
|
IL96531A
(en)
|
1989-12-11 |
1995-08-31 |
Univ Princeton |
History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
|
|
US5369108A
(en)
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
WO1994006802A1
(fr)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
TW438775B
(en)
|
1995-04-07 |
2001-06-07 |
Pharmacia & Upjohn Co Llc |
Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11) and related compounds
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
JP3354090B2
(ja)
|
1996-09-30 |
2002-12-09 |
シエーリング アクチエンゲゼルシャフト |
分化誘導剤
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
GB0108591D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CN1832939B
(zh)
|
2003-05-30 |
2010-04-28 |
杰明X医药品加拿大公司 |
用于治疗癌症或病毒病的三杂环化合物、组合物和方法
|
|
WO2005049593A2
(en)
|
2003-11-13 |
2005-06-02 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
CN1934091B
(zh)
|
2004-03-23 |
2012-02-08 |
辉瑞产品公司 |
治疗神经变性障碍的咪唑化合物
|
|
US7893278B2
(en)
|
2004-06-17 |
2011-02-22 |
Hoffman-La Roche Inc. |
CIS-imidazolines
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
CA2577752A1
(en)
|
2004-08-20 |
2006-03-02 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
|
|
DK1789390T3
(da)
|
2004-09-02 |
2012-02-27 |
Genentech Inc |
Pyridyl-inhibitorer af hedgehog-signalering
|
|
ATE554184T1
(de)
|
2004-12-16 |
2012-05-15 |
Harvard College |
Durch das nukleäre aminoxidase-homolog lsd1 vermittelte histondemethylierung
|
|
DE602005022826D1
(de)
|
2005-02-18 |
2010-09-23 |
Universitaetsklinikum Freiburg |
Kontrolle der Androgen Rezeptor-abhängigen Gen Expression durch Hemmung der Aminoxidase Aktivität der Lysin spezifischen Demethylase (LSD1)
|
|
HRP20100678T1
(hr)
|
2005-03-29 |
2011-02-28 |
Icos Corporation |
Derivati heteroariluree korisni kao inhibitori chk1
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
EP1888550B1
(en)
|
2005-05-12 |
2014-06-25 |
AbbVie Bahamas Ltd. |
Apoptosis promoters
|
|
WO2007015632A1
(en)
|
2005-08-04 |
2007-02-08 |
Cgk Co., Ltd. |
Atm and atr inhibitor
|
|
CA2619005A1
(en)
|
2005-08-10 |
2007-02-22 |
Johns Hopkins University |
Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
|
|
NL2000613C2
(nl)
|
2006-05-11 |
2007-11-20 |
Pfizer Prod Inc |
Triazoolpyrazinederivaten.
|
|
CL2007003244A1
(es)
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
WO2008127734A2
(en)
|
2007-04-13 |
2008-10-23 |
The Johns Hopkins University |
Lysine-specific demethylase inhibitors
|
|
JP2010540426A
(ja)
|
2007-09-25 |
2010-12-24 |
トポターゲット ユーケー リミテッド |
特定のヒドロキサム酸化合物の合成方法
|
|
CA2724325A1
(en)
|
2008-05-16 |
2009-11-19 |
Pharma Mar, S.A. |
Combination therapy with an antitumor alkaloid
|
|
WO2010011845A2
(en)
|
2008-07-24 |
2010-01-28 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods of preventing or treating viral infection or reactivation after latency in a host using inhibitors of the lsd1 protein
|
|
US8063043B2
(en)
|
2008-09-17 |
2011-11-22 |
Novartis Ag |
Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide
|
|
EP2361242B1
(en)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
NZ595708A
(en)
|
2009-05-26 |
2014-03-28 |
Abbvie Bahamas Ltd |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
US8389580B2
(en)
|
2009-06-02 |
2013-03-05 |
Duke University |
Arylcyclopropylamines and methods of use
|
|
EP2258865A1
(en)
|
2009-06-05 |
2010-12-08 |
Universitätsklinikum Freiburg |
Lysine-specific demethylase 1 (LSD1) is a biomarker for breast cancer
|
|
JPWO2010143582A1
(ja)
|
2009-06-11 |
2012-11-22 |
公立大学法人名古屋市立大学 |
フェニルシクロプロピルアミン誘導体及びｌｓｄ１阻害剤
|
|
AR077014A1
(es)
|
2009-06-19 |
2011-07-27 |
Lilly Co Eli |
Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
|
|
EP2467359A4
(en)
|
2009-08-18 |
2013-01-09 |
Univ Johns Hopkins |
(BIS-) UREA- AND (BIS-) THIOMINE COMPOUNDS AS EPIGENE MODULATORS OF THE LYSINE-SPECIFIC DEMETHYLASE 1 AND METHODS OF DISEASE TREATMENT THEREWITH
|
|
RU2602814C2
(ru)
|
2009-09-25 |
2016-11-20 |
Оризон Дженомикс С.А. |
Лизинспецифические ингибиторы деметилазы-1 и их применение
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
TWI600638B
(zh)
|
2010-01-22 |
2017-10-01 |
艾斯特隆製藥公司 |
作爲蛋白質去乙醯酶抑制劑之反式醯胺化合物及其使用方法
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
WO2011113005A2
(en)
|
2010-03-12 |
2011-09-15 |
The Johns Hopkins University |
Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo)
|
|
RS55348B1
(sr)
|
2010-04-19 |
2017-03-31 |
Oryzon Gnomics S A |
Inhibitori lizin specifične demetilaze-1 i njihova upotreba
|
|
CN102985402B
(zh)
|
2010-04-20 |
2015-04-29 |
罗马大学 |
反苯环丙胺衍生物作为组蛋白去甲基酶lsd1和/或lsd2的抑制剂
|
|
US8846935B2
(en)
|
2010-05-07 |
2014-09-30 |
Glaxosmithkline Llc |
Indazoles
|
|
UA110112C2
(uk)
|
2010-05-07 |
2015-11-25 |
Глаксосмітклайн Ллс |
Індоли
|
|
WO2011143651A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
WO2012013728A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
|
|
EP2598480B1
(en)
|
2010-07-29 |
2019-04-24 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
US9527805B2
(en)
|
2010-09-10 |
2016-12-27 |
Robert A. Casero |
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US20130303545A1
(en)
|
2010-09-30 |
2013-11-14 |
Tamara Maes |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
GB201112607D0
(en)
|
2011-07-22 |
2011-09-07 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
US8580762B2
(en)
|
2010-12-03 |
2013-11-12 |
Epizyme, Inc. |
Substituted purine and 7-deazapurine compounds
|
|
US20140163041A1
(en)
|
2011-02-08 |
2014-06-12 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
|
|
WO2012107498A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
EP2677865A4
(en)
|
2011-02-23 |
2015-04-22 |
Icahn School Med Mount Sinai |
BROMODOMAIN INHIBITORS AS MODULATORS OF GENE EXPRESSION
|
|
ES2951688T3
(es)
|
2011-02-28 |
2023-10-24 |
Epizyme Inc |
Compuestos de heteroarilo biciclico fusionados en 6,5 sustituidos
|
|
TWI530489B
(zh)
|
2011-03-22 |
2016-04-21 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯二氮呯酮化合物
|
|
EA023143B1
(ru)
|
2011-03-25 |
2016-04-29 |
Глэксосмитклайн Интеллекчуал Проперти (No.2) Лимитед |
Замещенный циклопропиламин в качестве ингибитора lsd1
|
|
JO3363B1
(ar)
|
2011-04-13 |
2019-03-13 |
Epizyme Inc |
مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
|
|
EP2741741A2
(en)
|
2011-05-19 |
2014-06-18 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for inflammatory diseases or conditions
|
|
US20140296255A1
(en)
|
2011-05-19 |
2014-10-02 |
Oryzong Genomics, S.A. |
Lysine demethylase inhibitors for thrombosis and cardiovascular diseases
|
|
AR087107A1
(es)
|
2011-07-27 |
2014-02-12 |
Lilly Co Eli |
Compuesto inhibidor de la señalizacion de la trayectoria notch
|
|
KR20140052018A
(ko)
|
2011-08-09 |
2014-05-02 |
다케다 야쿠힌 고교 가부시키가이샤 |
시클로프로판아민 화합물
|
|
JP6122006B2
(ja)
|
2011-08-15 |
2017-04-26 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション |
ヒストン脱メチル化酵素阻害剤としての、置換された（ｅ）−ｎ’−（１−フェニルエチリデン）ベンゾヒドラジド類似体
|
|
RU2668952C2
(ru)
*
|
2011-10-20 |
2018-10-05 |
Оризон Дженомикс, С.А. |
(гетеро)арилциклопропиламины в качестве ингибиторов lsd1
|
|
MX356344B
(es)
|
2011-10-20 |
2018-05-23 |
Oryzon Genomics Sa |
Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1.
|
|
NZ628762A
(en)
|
2012-02-10 |
2016-07-29 |
Constellation Pharmaceuticals Inc |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
EP2854809B1
(en)
|
2012-06-01 |
2017-12-06 |
Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI) |
Inhibitors of the notch signalling pathway and secretion for use in medicine
|
|
CN105051005B
(zh)
|
2012-10-12 |
2017-06-13 |
武田药品工业株式会社 |
环丙胺化合物及其用途
|
|
EP2927212A4
(en)
|
2012-11-28 |
2016-06-08 |
Univ Kyoto |
LSD1-SELECTIVE HEMMER WITH LYSINE STRUCTURE
|
|
WO2014085613A1
(en)
|
2012-11-30 |
2014-06-05 |
Mccord Darlene E |
Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
|
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
AU2014223990A1
(en)
|
2013-02-28 |
2015-09-10 |
Washington University |
Methods of treatment of human cytomegalovirus infection and diseases with bromodomain inhibitors
|
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
|
WO2014153001A1
(en)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
|
EP3003301B1
(en)
|
2013-05-30 |
2021-02-24 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
Novel suicidal lsd1 inhibitors targeting sox2-expressing cancer cells
|
|
NZ715331A
(en)
|
2013-06-19 |
2019-09-27 |
The Univ Of Utah Research Foundation |
Substituted (e)-n’-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
|
|
EP2829284A1
(en)
*
|
2013-07-22 |
2015-01-28 |
Deutsches Krebsforschungszentrum |
Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor
|
|
ES2734209T3
(es)
|
2013-08-06 |
2019-12-04 |
Imago Biosciences Inc |
Inhibidores de KDM1A para el tratamiento de enfermedades
|
|
US9556170B2
(en)
|
2013-08-30 |
2017-01-31 |
University Of Utah Research Foundation |
Substituted-1H-benzo[d]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors
|
|
CN116019921A
(zh)
*
|
2013-12-06 |
2023-04-28 |
Epizyme股份有限公司 |
用于治疗癌症的组合疗法
|
|
SI3080100T1
(sl)
|
2013-12-11 |
2023-04-28 |
Celgene Quanticel Research, Inc. |
Inhibitorji lizin specifične demetilaze-1
|
|
WO2015120281A1
(en)
|
2014-02-07 |
2015-08-13 |
Musc Foundation For Research Development |
Aminotriazole- and aminotetrazole-based kdm1a inhibitors as epigenetic modulators
|
|
SI3105218T1
(sl)
|
2014-02-13 |
2019-11-29 |
Incyte Corp |
Ciklopropilamini kot inhibitorji LSD1
|
|
EP3105219B9
(en)
|
2014-02-13 |
2018-10-03 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
MX373103B
(es)
|
2014-02-13 |
2020-04-17 |
Incyte Holdings Corp |
Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1).
|
|
JP2017508798A
(ja)
|
2014-03-07 |
2017-03-30 |
ザ ジョンズ ホプキンス ユニバーシティ |
ヒストンリジン特異的デメチラーゼ（ｌｓｄ１）およびヒストンデアセチラーゼ（ｈｄａｃ）の阻害剤
|
|
AR099994A1
(es)
|
2014-04-11 |
2016-08-31 |
Takeda Pharmaceuticals Co |
Compuesto de ciclopropanamina y sus usos
|
|
SI3137169T1
(sl)
|
2014-05-01 |
2022-04-29 |
Celgene Quanticel Research, Inc. |
Inhibitorji lizin specifične demetilaze-1
|
|
US10233165B2
(en)
|
2014-05-30 |
2019-03-19 |
Istituto Europeo Di Oncologia S.R.L. |
Cyclopropylamine compounds as histone demethylase inhibitors
|
|
RS60658B1
(sr)
|
2014-06-27 |
2020-09-30 |
Celgene Quanticel Research Inc |
Inhibitori lizin specifične demetilaze-1
|
|
EA201891526A3
(ru)
|
2014-07-03 |
2019-05-31 |
Селджен Квонтисел Рисёрч, Инк. |
Ингибиторы лизин-специфической деметилазы-1
|
|
US10414750B2
(en)
|
2014-07-03 |
2019-09-17 |
Celgene Quanticel Research, Inc. |
Inhibitors of lysine specific demethylase-1
|
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
TWI687419B
(zh)
|
2014-07-10 |
2020-03-11 |
美商英塞特公司 |
作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
WO2016025635A2
(en)
*
|
2014-08-13 |
2016-02-18 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
|
EP2993175A1
(en)
|
2014-09-05 |
2016-03-09 |
IEO - Istituto Europeo di Oncologia Srl |
Thienopyrroles as histone demethylase inhibitors
|
|
EA201790376A1
(ru)
|
2014-09-05 |
2017-08-31 |
Селджен Квонтисел Рисёрч, Инк. |
Ингибиторы лизин-специфической деметилазы-1
|
|
WO2016123387A1
(en)
|
2015-01-30 |
2016-08-04 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
PL3256218T3
(pl)
|
2015-02-12 |
2025-03-31 |
Imago Biosciences Inc. |
Inhibitor kdm1a i jego zastosowanie w terapii
|
|
CN106146361A
(zh)
|
2015-03-16 |
2016-11-23 |
四川大学 |
茚-1-亚基磺酰基苯甲酰肼衍生物及其制备方法和用途
|
|
EP3277689B1
(en)
|
2015-04-03 |
2019-09-04 |
Incyte Corporation |
Heterocyclic compounds as lsd1 inhibitors
|
|
CN106045862B
(zh)
|
2015-04-10 |
2019-04-23 |
上海迪诺医药科技有限公司 |
环丙胺类螺(杂)环化合物、其药物组合物及应用
|
|
WO2016172496A1
(en)
|
2015-04-23 |
2016-10-27 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
|
EP3090998A1
(en)
|
2015-05-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Solid forms
|
|
CA2987876A1
(en)
|
2015-06-12 |
2016-12-15 |
Oryzon Genomics, S.A. |
Biomarkers associated with lsd1 inhibitors and uses thereof
|
|
WO2017004519A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Utah Research Foundation |
Substituted benzohydrazide analogs as histone demethylase inhibitors
|
|
WO2017013061A1
(en)
|
2015-07-17 |
2017-01-26 |
Oryzon Genomics, S.A. |
Biomarkers associated with lsd1 inhibitors and uses thereof
|
|
LT3334709T
(lt)
|
2015-08-12 |
2025-03-10 |
Incyte Holdings Corporation |
Lsd1 inhibitoriaus druskos
|
|
CN105233292B
(zh)
*
|
2015-10-19 |
2018-03-13 |
中国科学院北京基因组研究所 |
Ory‑1001联合放疗和化疗用于治疗人三阴性乳腺癌的用途
|
|
CN105541806A
(zh)
|
2015-12-25 |
2016-05-04 |
中国药科大学 |
巴比妥酸类化合物、制备方法及其应用
|
|
CN105924362B
(zh)
|
2016-02-05 |
2018-08-17 |
上海龙翔生物医药开发有限公司 |
芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
|
|
CN109462980B
(zh)
|
2016-03-15 |
2022-02-08 |
奥莱松基因组股份有限公司 |
用于治疗血液恶性肿瘤的lsd1抑制剂的组合
|
|
ES3057783T3
(en)
|
2016-03-15 |
2026-03-04 |
Oryzon Genomics Sa |
Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases
|
|
WO2017158136A1
(en)
|
2016-03-16 |
2017-09-21 |
Oryzon Genomics, S.A. |
Methods to determine kdm1a target engagement and chemoprobes useful therefor
|
|
CN106045881B
(zh)
|
2016-05-26 |
2017-10-31 |
新乡医学院 |
一类白藜芦醇衍生物、其制备方法及作为lsd1抑制剂的应用
|